相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alzheimer's Disease Genetics: A Dampened Microglial Response?
Zena K. Chatila et al.
NEUROSCIENTIST (2023)
Functional insights from biophysical study of TREM2 interactions with apoE and Aβ1-42
Daniel L. Kober et al.
ALZHEIMERS & DEMENTIA (2021)
CD33-Targeted Therapies: Beating the Disease or Beaten to Death?
Joseph E. Maakaron et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Molecular structure of a prevalent amyloid-β fibril polymorph from Alzheimer's disease brain tissue
Ujjayini Ghosh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Prior activation state shapes the microglia response to antihuman TREM2 in a mouse model of Alzheimer's disease
Daniel C. Ellwanger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
The role of innate immune genes in Alzheimer's disease
Ana Griciuc et al.
CURRENT OPINION IN NEUROLOGY (2021)
Development of a robust crystallization platform for immune receptor TREM2 using a crystallization chaperone strategy
Noel J. Byrne et al.
PROTEIN EXPRESSION AND PURIFICATION (2021)
Direct control of CAR T cells through small molecule-regulated antibodies
Spencer Park et al.
NATURE COMMUNICATIONS (2021)
Dense-core plaques could be beneficial in AD
Ian Fyfe
Nature Reviews Neurology (2021)
Neurotoxic Soluble Amyloid Oligomers Drive Alzheimer's Pathogenesis and Represent a Clinically Validated Target for Slowing Disease Progression
Martin Tolar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Highly accurate protein structure prediction with AlphaFold
John Jumper et al.
NATURE (2021)
Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice
Kathleen M. Schoch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain
Aleksandra Szykowska et al.
STRUCTURE (2021)
Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer's disease
Nicholas F. Fitz et al.
NATURE COMMUNICATIONS (2021)
CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin
Matteo Molica et al.
CANCERS (2021)
Siglecs as Immune Cell Checkpoints in Disease
Shiteng Duan et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Gene therapy for neurodegenerative disorders: advances, insights and prospects
Wei Chen et al.
ACTA PHARMACEUTICA SINICA B (2020)
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Kai Schlepckow et al.
EMBO MOLECULAR MEDICINE (2020)
Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives
Bruno P. Imbimbo et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
The role of innate immunity in Alzheimer's disease
Hannah E. Ennerfelt et al.
IMMUNOLOGICAL REVIEWS (2020)
γ-Secretase cleavage of the Alzheimer risk factor TREM2 is determined by its intrinsic structural dynamics
Andrea Steiner et al.
EMBO JOURNAL (2020)
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
Nicolai Franzmeier et al.
MOLECULAR NEURODEGENERATION (2020)
Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies
Sara Linse et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Brian W. Kunkle et al.
NATURE GENETICS (2019)
Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer
Andrew M. Petros et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Ana Griciuc et al.
NEURON (2019)
Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development
Knut Biber et al.
FRONTIERS IN PHARMACOLOGY (2019)
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue
Marius Kollmer et al.
NATURE COMMUNICATIONS (2019)
Structural basis of Notch recognition by human γ-secretase
Guanghui Yang et al.
NATURE (2019)
Recognition of the amyloid precursor protein by human γ-secretase
Rui Zhou et al.
SCIENCE (2019)
Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis
Luke A. Miles et al.
ISCIENCE (2019)
Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers
Justin P. Lomont et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2018)
Anti-Amyloid-β Monoclonal Antibodies for Alzheimer's Disease: Pitfalls and Promise
Christopher H. van Dyck
BIOLOGICAL PSYCHIATRY (2018)
Investigational CD33-targeted therapeutics for acute myeloid leukemia
Roland B. Walter
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2
Athena Sudom et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Cell-specific production, secretion, and function of apolipoprotein E
Maaike Kockx et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2018)
TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function
Yingjun Zhao et al.
NEURON (2018)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach
Nicolas Henry et al.
PLOS COMPUTATIONAL BIOLOGY (2018)
Are N- and C-terminally truncated A species key pathological triggers in Alzheimer's disease?
Julie Dunys et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
THE AMYLOID HYPOTHESIS ON TRAIL
Simon Makin
NATURE (2018)
Microglia: Housekeeper of the Central Nervous System
John Alimamy Kabba et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2018)
Studies on the Detection, Expression, Glycosylation, Dimerization, and Ligand Binding Properties of Mouse Siglec-E
Shoib Siddiqui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Susanne Krasemann et al.
IMMUNITY (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
In situ fibrillizing amyloid- beta 1-42 induces neurite degeneration and apoptosis of differentiated SH-SY5Y cells
Jekaterina Krishtal et al.
PLOS ONE (2017)
Small things matter: Implications of APP intracellular domain AICD nuclear signaling in the progression and pathogenesis of Alzheimer's disease
Hassan Bukhari et al.
PROGRESS IN NEUROBIOLOGY (2017)
Fibril structure of amyloid-β(1-42) by cryo-electron microscopy
Lothar Gremer et al.
SCIENCE (2017)
Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease
Sudhakar R. Subramaniam et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences
Philip F. Copenhaver et al.
Frontiers in Molecular Neuroscience (2017)
Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10
Tom C. M. Seegar et al.
CELL (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease
Hadas Keren-Shaul et al.
CELL (2017)
Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation
Wilbur Song et al.
ALZHEIMERS & DEMENTIA (2017)
A New Perspective of Lysosomal Cation Channel-Dependent Homeostasis in Alzheimer's Disease
Martin Ezeani et al.
MOLECULAR NEUROBIOLOGY (2016)
Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status
Laura Piccio et al.
ACTA NEUROPATHOLOGICA (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Aβ-Immunotherapeutic strategies: a wide range of approaches for Alzheimer's disease treatment
Laia Montoliu-Gaya et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2016)
Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates
Mihirbaran Mandal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease
Amanda Heslegrave et al.
MOLECULAR NEURODEGENERATION (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy
Peng Yuan et al.
NEURON (2016)
TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
Felix L. Yeh et al.
NEURON (2016)
Early changes in CSF sTREM2 in dominantly inherited Alzheimer's disease occur after amyloid deposition and neuronal injury
Marc Suarez-Calvet et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
APP Receptor? To Be or Not To Be
Carole Deyts et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Implications of GABAergic Neurotransmission in Alzheimer's Disease
Yanfang Li et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms
Daniel L. Kober et al.
ELIFE (2016)
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch et al.
SCIENTIFIC REPORTS (2016)
Interactions of innate and adaptive immunity in brain development and function
Anthony J. Filiano et al.
BRAIN RESEARCH (2015)
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Yuka Atagi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Charles C. Bailey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Aβ42 and Aβ40: similarities and differences
Tian Qiu et al.
JOURNAL OF PEPTIDE SCIENCE (2015)
Innate immunity in Alzheimer's disease
Michael T. Heneka et al.
NATURE IMMUNOLOGY (2015)
Microglial cell dysregulation in brain aging and neurodegeneration
Rommy von Bernhardi et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes
Hoang S. Nhan et al.
ACTA NEUROPATHOLOGICA (2015)
Clearance of Amyloid-Beta in Alzheimer's Disease: Shifting the Action Site from Center to Periphery
Yu-Hui Liu et al.
MOLECULAR NEUROBIOLOGY (2015)
Molecular basis for mid-region amyloid-β capture by leading Alzheimer's disease immunotherapies
Gabriela A. N. Crespi et al.
SCIENTIFIC REPORTS (2015)
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Amy Reeve et al.
AGEING RESEARCH REVIEWS (2014)
Lessons from a BACE1 inhibitor trial: Off-site but not off base
Debomoy K. Lahiri et al.
ALZHEIMERS & DEMENTIA (2014)
Coding variants in TREM2 increase risk for Alzheimer's disease
Sheng Chih Jin et al.
HUMAN MOLECULAR GENETICS (2014)
Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4
Letta Argyri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Nanoprobing of misfolding and interactions of amyloid β 42 protein
Bo-Hyun Kim et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
A three-dimensional human neural cell culture model of Alzheimer's disease
Se Hoon Choi et al.
NATURE (2014)
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor
Andrew J. Brooks et al.
SCIENCE (2014)
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis
Gernot Kleinberger et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Crystal structure reveals conservation of amyloid-beta conformation recognized by 3D6 following humanization to bapineuzumab
Hadar Feinberg et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis
George S. Bloom
JAMA NEUROLOGY (2014)
Molecular Structure of β-Amyloid Fibrils in Alzheimer's Disease Brain Tissue
Jun-Xia Lu et al.
CELL (2013)
Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease: A Phase I, Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study
Jaren W. Landen et al.
CLINICAL NEUROPHARMACOLOGY (2013)
Structure, expression pattern and biological activity of molecular complex TREM-2/DAP12
Agnieszka Paradowska-Gorycka et al.
HUMAN IMMUNOLOGY (2013)
Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage
Patrick Wunderlich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Soluble amyloid-β precursor protein binds its cell surface receptor in a cooperative fashion with glypican and syndecan proteoglycans
Constanze Reinhard et al.
JOURNAL OF CELL SCIENCE (2013)
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
Victor L. Villemagne et al.
LANCET NEUROLOGY (2013)
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Thorlakur Jonsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
TREM2 Variants in Alzheimer's Disease
Rita Guerreiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation
Luke A. Miles et al.
SCIENTIFIC REPORTS (2013)
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Krista L. Moulder et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
APP dimer formation is initiated in the endoplasmic reticulum and differs between APP isoforms
Simone Isbert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
Gantenerumab: A Novel Human Anti-Aβ Antibody Demonstrates Sustained Cerebral Amyloid-β Binding and Elicits Cell-Mediated Removal of Human Amyloid-β
Bernd Bohrmann et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
The Amyloid Precursor Protein Copper Binding Domain Histidine Residues 149 and 151 Mediate APP Stability and Metabolism
Loredana Spoerri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Structural Basis of C-terminal β-Amyloid Peptide Binding by the Antibody Ponezumab for the Treatment of Alzheimer's Disease
Sherry L. La Porte et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Metal Binding Dictates Conformation and Function of the Amyloid Precursor Protein (APP) E2 Domain
Sven O. Dahms et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Functions of Aß, sAPPa and sAPPß: similarities and differences
Stephanie Chasseigneaux et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Cross-Linking of Cell Surface Amyloid Precursor Protein Leads to Increased β-Amyloid Peptide Production in Hippocampal Neurons: Implications for Alzheimer's Disease
Roger Lefort et al.
JOURNAL OF NEUROSCIENCE (2012)
Neutralization of Soluble, Synaptotoxic Amyloid β Species by Antibodies Is Epitope Specific
Wagner Zago et al.
JOURNAL OF NEUROSCIENCE (2012)
An Effector-Reduced Anti-β-Amyloid (Aβ) Antibody with Unique Aβ Binding Properties Promotes Neuroprotection and Glial Engulfment of Aβ
Oskar Adolfsson et al.
JOURNAL OF NEUROSCIENCE (2012)
Distinct Dimerization for Various Alloforms of the Amyloid-Beta Protein: Aβ1-40, Aβ1-42, and Aβ1-40(D23N)
Sebastien Cote et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2012)
Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology
Pritam Das et al.
MOLECULAR NEURODEGENERATION (2012)
Genome-wide association study of Alzheimer's disease with psychotic symptoms
P. Hollingworth et al.
MOLECULAR PSYCHIATRY (2012)
Sting of Alzheimer's failures offset by upcoming prevention trials
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
A partially folded structure of amyloid-beta(1-40) in an aqueous environment
Subramanian Vivekanandan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Dissociation of Apolipoprotein E Oligomers to Monomer Is Required for High-Affinity Binding to Phospholipid Vesicles
Kanchan Garai et al.
BIOCHEMISTRY (2011)
Crystal Structure of C-terminal Truncated Apolipoprotein A-I Reveals the Assembly of High Density Lipoprotein (HDL) by Dimerization
Xiaohu Mei et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Aβ40 and Aβ42 Amyloid Fibrils Exhibit Distinct Molecular Recycling Properties
Laia Sanchez et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Sink Hypothesis and Therapeutic Strategies for Attenuating Aβ Levels
Yan Zhang et al.
NEUROSCIENTIST (2011)
Biophysical Characterization of Aβ42 C-Terminal Fragments: Inhibitors of Aβ42 Neurotoxicity
Huiyuan Li et al.
BIOCHEMISTRY (2010)
The Association-Dissociation Behavior of the ApoE Proteins: Kinetic and Equilibrium Studies
Kanchan Garai et al.
BIOCHEMISTRY (2010)
Amyloid-beta as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Microglial Activation and Chronic Neurodegeneration
Melinda E. Lull et al.
NEUROTHERAPEUTICS (2010)
Structure and biochemical analysis of the heparin-induced E1 dimer of the amyloid precursor protein
Sven O. Dahms et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
What is the role of amyloid precursor protein dimerization?
Naouel Ben Khalifa et al.
CELL ADHESION & MIGRATION (2010)
Structural Characterization of a Soluble Amyloid β-Peptide Oligomer
Liping Yu et al.
BIOCHEMISTRY (2009)
Induced Dimerization of the Amyloid Precursor Protein Leads to Decreased Amyloid-β Protein Production
Simone Eggert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease
Summer L. Bernstein et al.
NATURE CHEMISTRY (2009)
Stabilization of neurotoxic soluble β-sheet-rich conformations of the Alzheimer's disease amyloid-β peptide
Deborah J. Tew et al.
BIOPHYSICAL JOURNAL (2008)
Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2
Jens Radzimanowski et al.
EMBO REPORTS (2008)
Immunotherapy reduces vascular amyloid-β in PDAPP mice
Sally Schroeter et al.
JOURNAL OF NEUROSCIENCE (2008)
Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Anant K. Paravastu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phosphorylated ITIMs enable ubiquitylation of an inhibitory cell surface receptor
Roland B. Walter et al.
TRAFFIC (2008)
ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2
Roland B. Walter et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Copper binding to the Alzheimer's disease amyloid precursor protein
Geoffrey K. -W. Kong et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2008)
Structure of Alzheimer's disease amyloid precursor protein copper-binding domain at atomic resolution
Geoffrey Kwai-Wai Kong et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2007)
Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions
Geoffrey K. -W. Kong et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover
Selinda J. Orr et al.
BLOOD (2007)
Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis
Harald Neumann et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Aβ in distal axons
Mee-Sook Song et al.
NEUROBIOLOGY OF AGING (2006)
Molecular structure of amyloid fibrils: insights from solid-state NMR
Robert Tycko
QUARTERLY REVIEWS OF BIOPHYSICS (2006)
A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing
T Hernandez-Caselles et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2
K Takahashi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity
RB Walter et al.
BLOOD (2005)
Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
DM Wilcock et al.
NEUROBIOLOGY OF DISEASE (2004)
Effect of different anti-Aβ antibodies on Aβ fibrillogenesis as assessed by atomic force microscopy
J Legleiter et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Solid state NMR reveals a pH-dependent antiparallel β-sheet registry in fibrils formed by a β-amyloid peptide
AT Petkova et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
The X-ray structure of an antiparaliel dimer of the human amyloid precursor protein E2 domain
YC Wang et al.
MOLECULAR CELL (2004)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Differential binding to human FcγRIIa and FcγRIIb receptors by human IgG wildtype and mutant antibodies
KL Armour et al.
MOLECULAR IMMUNOLOGY (2003)
Structure of the Alzheimer's disease amyloid precursor protein copper binding domain - A regulator of neuronal copper homeostasis
KJ Barnham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells
HK Anandatheerthavarada et al.
JOURNAL OF CELL BIOLOGY (2003)
Epitope and isotype specificities of antibodies to β-amyloid peptide for protection against Alzheimer's disease-like neuropathology
F Bard et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Amyloid β-protein (Aβ) assembly:: Aβ40 and Aβ42 oligomerize through distinct pathways
G Bitan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment -: Similarity with a virus fusion domain
O Crescenzi et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Kinetic studies of amyloid β-protein fibril assembly -: Differential effects of α-helix stabilization
Y Fezoui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Identification and characterization of key kinetic intermediates in amyloid β-protein fibrillogenesis
MD Kirkitadze et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease
S Scheuermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Fibulin-1 binds the amino-terminal head of β-amyloid precursor protein and modulates its physiological function
I Ohsawa et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Structure of the protease domain of memapsin 2 (β-secretase) complexed with inhibitor
L Hong et al.
SCIENCE (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia
MI Brazil et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The Alzheimer's peptide Aβ adopts a collapsed coil structure in water
S Zhang et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Review:: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
S Varadarajan et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
分享论文
